13 results
IGIV in Neurology — Evidence and Recommendations
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 26 / Issue 2 / May 1999
- Published online by Cambridge University Press:
- 05 August 2019, pp. 139-152
-
- Article
-
- You have access
- Export citation
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update – ERRATUM
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 44 / Issue 4 / July 2017
- Published online by Cambridge University Press:
- 05 January 2016, p. 467
-
- Article
-
- You have access
- HTML
- Export citation
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 42 / Issue 6 / November 2015
- Published online by Cambridge University Press:
- 27 October 2015, pp. 372-380
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring
- Part of
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 42 / Issue 3 / May 2015
- Published online by Cambridge University Press:
- 21 April 2015, pp. 159-167
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
The Toronto Observational Study of Natalizumab in Multiple Sclerosis
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 38 / Issue 3 / May 2011
- Published online by Cambridge University Press:
- 02 December 2014, pp. 422-428
-
- Article
-
- You have access
- Export citation
Adherence to Multiple Sclerosis Disease-Modifying Therapies in Ontario is Low
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 38 / Issue 3 / May 2011
- Published online by Cambridge University Press:
- 02 December 2014, pp. 429-433
-
- Article
-
- You have access
- Export citation
Natalizumab Risk Stratification: Role of a Two- Step Anti-JCV Antibody Assay
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 39 / Issue 5 / September 2012
- Published online by Cambridge University Press:
- 02 December 2014, pp. 670-675
-
- Article
-
- You have access
- Export citation
Increasing Use of Disease Modifying Drugs for MS in Canada
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 37 / Issue 3 / May 2010
- Published online by Cambridge University Press:
- 02 December 2014, pp. 383-388
-
- Article
-
- You have access
- Export citation
Use of Natalizumab in Multiple Sclerosis Patients
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 37 / Issue 1 / January 2010
- Published online by Cambridge University Press:
- 02 December 2014, pp. 98-104
-
- Article
-
- You have access
- Export citation
Multiple Sclerosis Disease-Modifying Therapy Prescribing Patterns in Ontario
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 40 / Issue 1 / January 2013
- Published online by Cambridge University Press:
- 23 September 2014, pp. 67-72
-
- Article
-
- You have access
- Export citation
Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects
-
- Journal:
- Proceedings of the Nutrition Society / Volume 73 / Issue 4 / November 2014
- Published online by Cambridge University Press:
- 13 May 2014, pp. 441-451
-
- Article
-
- You have access
- HTML
- Export citation
Chapter 35 - Teriflunomide to treat multiple sclerosis
- from Section III - Clinical trials of multiple sclerosis therapies
-
-
- Book:
- Multiple Sclerosis Therapeutics
- Published online:
- 05 December 2011
- Print publication:
- 20 October 2011, pp 410-417
-
- Chapter
- Export citation
Contributors
-
-
- Book:
- Multiple Sclerosis Therapeutics
- Published online:
- 05 December 2011
- Print publication:
- 20 October 2011, pp viii-xii
-
- Chapter
- Export citation